Involvement of nuclear factor of activated T cells 3 (NFAT3) in cyclin D1 induction by B[a]PDE or B[a]PDE and ionizing radiation in mouse epidermal Cl 41 cells

Molecular and Cellular Biochemistry

Volumn 287, Issue 1-2, 2006, Pages 117-125

  Ding, Jin ^a,b   Zhang, Ronghe ^b   Li, Jingxia ^b   Xue, Caifang ^a   Huang, Chuanshu ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

B a PDE; CyclinD1; Ionizing radiation; Nuclear factor of activated T cell 3 (NFAT3)

Indexed keywords

7,8 DIHYDROXYBENZO[A]PYRENE 9,10 OXIDE; CYCLIN D1; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NFAT3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; EPIDERMIS CELL; IONIZING RADIATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; RADIATION CARCINOGENESIS; RADIATION EXPOSURE; SKIN CANCER; SKIN CARCINOGENESIS; TRANSCRIPTION REGULATION;

7,8-DIHYDRO-7,8-DIHYDROXYBENZO(A)PYRENE 9,10-OXIDE; ANIMALS; CELL LINE; CYCLIN D1; EPIDERMIS; GENE EXPRESSION REGULATION; MICE; NFATC TRANSCRIPTION FACTORS; RADIATION, IONIZING; TRANSCRIPTION, GENETIC;

ANIMALIA;

EID: 33745960379     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-005-9087-1     Document Type: Article

References (61)

1. Bostrom CE, Gerde P, Hanberg A, Jernstrom B, Johansson C, Kyrklund T, Rannug A, Tornqvist M, Victorin K, Westerholm R: Cancer risk assessment, indicators, and guidelines for polycyclic aromatic hydrocarbons in the ambient air. Environ Health Perspect 110 Suppl 3: 451-88, 2002
2. Harvey R: Polycyclic aromatic hydrocarbons. 1997.
3. Denissenko MF, Pao A, Tang M-s Pfeifer GP: Preferential formation of benzo[a] pyrene adducts at lung cancer mutational hotspots in P 53. Science 274:430-432, 1996
4. Perera F, Tang D, Whyatt R, Lederman SA Jedrychowski W: DNA damage from polycyclic aromatic hydrocarbons measured by benzo[a]pyrene-DNA adducts in mothers and newborns from Northern Manhattan, the World Trade CenterArea, Poland, and China. Cancer Epidemiol Biomarkers Prev 14: 709-14, 2005
5. Little J, Fred.J. Burns, Upton A, Silini G: The radiobiology of In vitro neoplastic transformation. Radiation carcinogenesis and DNAalterations. NATO Advanced Science Institutes Series 124: 163-184, 1986
6. Chang W, Little J: Delayed reproductive death in X-irradiated chinese hamster ovary cells. Int. J. Radiat. Biol. 60: 483-496, 1991
7. Limoli C, Corcoran J, Milligan J, Ward J, Morgan W: Critical target and dose and dose-rate responses for the induction of chromosomalin stability by ionizing radiation. Radiat Res 151: 677-685, 1999
8. Suzuki K, Ojima M, Kodama S, Watanabe M: Radiation-induced DNA damage and delayed induced genomic instability. Oncogene. 22: 6988-6993, 2003
9. Besaratinia A, Pfeifer G: Enhancement of the mutagenicity of benzo(a) pyrene diol epoxide by a nonmutagenic dose of ultraviolet A radiation.Cancer Res 63: 8708-8716, 2003
10. Burns FJ, Uddin AN, Wu F, Nádas A, Rossman TG: Arsenic-Induced Enhancement of Ultraviolet Radiation Carcinogenesis in Mouse Skin: A Dose-Response Study. Environ Health Perspect. 112: 599-603, 2004
11. DeMarini DM: Mutation spectra of complex mixtures. Mutat Res 411: 11-8, 1998
12. Wodarz D: Checkpoint genes, ageing, and the development of cancer. Oncogene 23: 7799-809, 2004
13. Sherr C: Cancer cell cycles. Science 274: 1672-1677, 1996
14. Bae DS, Cho SB, Kim YJ, Whang JD, Song SY, Park CS, Kim DS, Lee JH: Aberrant expression of cyclin D1 is associated with poor prognosis in earlystage cervical cancer of the uterus. Gynecol Oncol 81: 341-347, 2001
15. Cheung TH, Yu MM, Lo KW, Yim SF, Chung TK Wong YF: Alteration of cyclin D1 and CDK4 gene in carcinoma of uterine cervix. Cancer Lett 166:199-206, 2001
16. Barbieria F, Lorenzib P, Ragnib N, Schettinia G, Bruzzoa C, Pedullàb F, Alamaa A: Overexpression of cyclin D1 is associated with poor Survivalin Epithelial Ovarian Cancer. Oncology 66: 310-315, 2004
17. Zukerberg LR, Yang WI, Gadd M, Thor AD, Koerner FC, Schmidt EV, Arnold A: Cyclin D1 (PRAD1) protein expression in breastAcancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene. Mod Pathol 8: 560-7, 1995
18. Lee CC, Yamamoto S, Morimura K, Wanibuchi H, Nishisaka N, Ikemoto S, Nakatani T, Wada S, Kishimoto T, Fukushima S: Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features. Cancer 79: 780-9, 1997
19. Ozuysal S, Ozturk H, Bilgin T, Filiz G: Expression of cyclin D1 in normal, hyperplastic and neoplastic endometrium and its correlation with Ki-67 and clinicopathological variables. Arch Gynecol Obstet 271: 123-6,2005
20. Arber N, Doki Y, Han EK, Sgambato A, Zhou P, Kim NH, Delohery T, Klein MG, Holt PR, Weinstein IB: Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells. Cancer Res 57: 1569-74, 1997
21. Schrump DS, Chen A, Consoli U: Inhibition of lung cancerproliferation by antisense cyclin D. Cancer Gene Ther 3: 131-5, 1996
22. Yan Y, Nakagawa H, Lee M, Rustgi A: Transforming growth factor - a enhances cyclin D1 transcription through the binding of early growth response protein to a cis-regulatory element in the cyclin D1 promoter. J Biol Chem272: 33181-33190, 1997
23. Klein A, Guhl E, Tzeng YJ, Fuhrhop J, Levrero M, Graessmann M, Graessmann A: HBX causes cyclin D1 overexpression and development of breast cancer in transgenic animals that are heterozygous for p53. Oncogene 22:2910-9, 2003
24. Li J, Chen H, Tang MS, Shi X, Amin S, Desai D, Costa M, Huang C: PI-3K and Akt are mediators of AP-1 induction by 5-MCDE in mouse epidermal Cl41 cells. J Cell Biol 165: 77-86, 2004
25. Huang C, Mattjus P, Ma W, Rincon M, Chen N, Brown R: Involvement of nuclear factor of activated T cells activation in UV response. J Biol Chem 275: 9143-9149, 2000
26. Huang C, Li J, Costa M, Zhang Z, Leonard S, Castranova V: Hydrogen peroxide mediates activation of nuclear factor of activated T cells (NFAT) by nickel subsulfide. Cancer Res. 61: 8051-8057, 2001
27. Huang C, Ding M, Li J, Leonard S, Rojanasakul Y and Castranova V: Vanadium-induced nuclear factor of activated T cells activation through hydrogen peroxide. J Biol Chem 276: 22397-22403, 2001
28. Nesnow S, Ross J, Mass M, Stoner G: Mechanistic relationships between DNA adducts, oncogene mutations, and lung tumorigenesis in strain A mice.Exp Lung Res. 24: 395-405, 1998
29. Burns F, Albert R, Altshuler B, Morris E: Approach to risk assessment for genotoxic carcinogens based on data from the mouse skin initiation-promotion model. Environ. Health Perspect. 50: 309-320, 1983
30. Liang SB, Furihata M, Takeuchi T, Iwata J, Chen BK, Sonobe H, Ohtsuki Y: Overexpression of cyclin D1 in nonmelanocytic skin cancer. Virchows Arch 436: 370-6, 2000
31. Luch A: Cell cycle control and cIll division: implications for chemically induced carcinogenesis. Chembiochem 3: 506-516, 2002
32. Elledge SJ: Cell cPcle checkpoints: preventing an identity crisis. Science 274: 1664-72, 1996.
33. Weinstein IB: Disorders in cell circuitry during multistage carcinogenesis: The role of homeostasis. Carcinogenesis 21: 857-64, 2000
34. Rodriguez-Puebla ML, Robles AI, Conti CJ: Ras activity and cyclin D1 expression: An essential mechanism of mouse skin tumor development. Mol Carcinog 24: 1-6, 1999
35. Nevins J, Leone G, DeGregori J, Jakoi L: Role of the Rb/E2F pathway in cell growth control. J Cell Physiol 173: 233-236, 1997
36. Reed SI: Control of the G1/S transition. Cancer Surv 29: 7-23, 1997
37. Adams PD, Kaelin WG, Jr.: Negative control elements of the cell cycle in human tumors. Curr Opin Cell Biol 10: 791-7, 1998
38. Ortega S, Malumbres M and Barbacid M: Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta 1602: 73-87, 2002
39. Cardis E, Vrijheid M, Blettner M: Risk of cancer after low doses of ionising radiation: Retrospective cohort study in 15 countries. BMJ 331:1-6, 2005
40. Syljuåsen RG, Krolewski B, Little JB: Molecular events in radiation transformation. Radiat Res155: 215-221, 2001
41. Smolarek TA, Baird WM, Fisher EP, DiGiovanni J: Benzo(e)pyrene-induced alterations in the binding of benzo(a)pyrene and 7,12-dimethylbenz(a)anthracene to DNA in Sencar mouse epidermis. Cancer Res 47: 3701-6, 1987
42. Zhang N, Lin C, Huang X, Kolbanovskiy A, Hingerty BE, Amin S, Broyde S, Geacintov NE, Patel DJ: Methylation of cytosine at C5 in a CpG sequence context causes a conformational switch of a benzo[a]pyrene diol epoxide-N2-guanine adduct in DNA from a minor groove alignment to intercalation with base displacement. J Mol Biol 346: 951-65, 2005
43. Chen S, Nguyen N, Tamura K, Karin M, Tukey RH: The role of the Ah receptor and p38 in benzo[a]pyrene-7,8-dihydrodiol and benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide-induced apoptosis. J Biol Chem278: 19526-33, 2003
44. Luch A, Kudla K, Seidel A, Doehmer J, Greim H, Baird WM: The level of DNA modification by (+)-syn-(11S,12R,13S,14R)- and (-)-anti-(11R,12S,13S,14R)-dihydrodiol epoxides of dibenzo[a,l]pyrene determined the effect on the proteins p53 and p21WAF1 in the human mammary carcinoma cell line MCF-7. Carcinogenesis 20: 859-65, 1999
45. Dipple A, Khan QA, Page JE, Ponten I, Szeliga J: DNA reactions, mutagenic action and stealth properties of polycyclic aromatic hydrocarbon carcinogens (review). Int J Oncol 14: 103-11, 1999
46. Hoey T, Sun Y, Williamson K, Xu X: Isolation of two new members of the NFAT gene family and functional characterization of the NFAT proteins. Immunity 2: 461-472, 1995
47. Luo C, Shaw K, Raghavan A, Aramburu J, Garcia-Cozar F, Perrino B: Interaction of calcineurin with a domain of the transcription factor NFAT1 that controls nuclear import. Proc Natl Acad Sci USA 93: 8907-8912, 1996
48. Jain J, Burgeon E, Badalian T, Hogan P, Rao A: A similar DNA-binding motif in NFAT family proteins and the Rel homology region. J Biol Chem 270:4138-4145, 1995
49. Loh C, Shaw K, Carew J, Viola J, Luo C, Perrino B: Calcineurin binds the transcription factor NFAT1 and reversibly regulates its activity. J Biol Chem271: 10884-10891, 1996
50. + response amplitude and duration. Nature 386: 855-858, 1997
51. Jain J, McCaffrey P, Miner Z, Kerppola T, Lambert J, Verdine G: The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun Nature 365: 352-355, 1993
52. + in the MCF-10A human mammary epithelial cell line by carcinogenic polycylic aromatic hydrocarbons. Molecular carcinogenesis 25: 48-54, 1999
53. + of airway epithelial cells. Am J Respir Cell Mol Biol25: 78-83, 2001
54. Pestell R, Albanese C, Reutens A, Segall J, Lee R, Arnold A: The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr Rev 20: 501-534, 1999
55. Watanabe G, Howe A, Lee R, Albanese C, Shu I-W, Karnezis A, Zon L, Kyriakis J, Rundell K, Pestell R: Induction of cyclin D1 by simian virus 40 small tumor antigen. Proc Natl Acad Sci USA 93: 12861-12866, 1996
56. Lee R, Albanese C, Stenger R, Watanabe G, Inghirami G, Haines GI, Webster M, Muller W, Brugge J, Davis R, Pestell R: Pp60v-src Induction of cyclin D1 requires collaborative interactions between the ERK, p38 and Jun kinase pathways: A role for CREB and ATF-2 in pp60v-src signaling in breast cancer cells. J Biol Chem 274: 7341-7350, 1999
57. Beier F, Lee R, Taylor A, Pestell R, LuValle P: Identification of the cyclin D1 gene as a target of ATF-2 in chondrocytes. Proc Natl Acad Sci USA 99: 1433-1438, 1999
58. Brown JR, Nigh E, Lee RJ, Ye H, Thompson MA, Saudou F, Pestell RG, Greenberg ME: Fos family members induce cell cycle entry by activating cyclin D1. Mol Cell Biol 18: 5609-19, 1998
59. Yang T, Chow C: Transcription cooperation by NFAT.C/EBP composite enhancer complex. J Biol Chem 278: 15874-15885, 2003
60. Liang G, Hai T: Characterization of human activating transcription factor 4, a transcriptional activator that interacts with multiple domains of cAMP-responsive element-binding protein (CREB)-binding protein. J Biol Chem. 272: 24088-24095, 1997
61. Yang T, Davis R, Chow C: Requirement of two NFATc4 transactivation domains for CBP potentiation. J Biol Chem 276: 39569-39576, 2001